Grabowski BA[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
1994	1
1997	1
2004	1
2006	3
2010	1
2011	1
2023	0

Page 1

The effect of hepatic insufficiency on the safety and pharmacokinetics of paricalcitol (Zemplar).

Carr RA, André AK, Chen P, Grabowski BA, Chang MS, Locke CS, Williams LA, Chojkier M. Carr RA, et al. Among authors: grabowski ba. Nephron Clin Pract. 2006;103(3):c100-5. doi: 10.1159/000092018. Epub 2006 Mar 13. Nephron Clin Pract. 2006. PMID: 16534233

The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase.

Khosravan R, Grabowski BA, Mayer MD, Wu JT, Joseph-Ridge N, Vernillet L. Khosravan R, et al. Among authors: grabowski ba. J Clin Pharmacol. 2006 Jan;46(1):88-102. doi: 10.1177/0091270005282634. J Clin Pharmacol. 2006. PMID: 16397288 Clinical Trial.

Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.

Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber BW. Denissen JF, et al. Among authors: grabowski ba. Drug Metab Dispos. 1997 Apr;25(4):489-501. Drug Metab Dispos. 1997. PMID: 9107549

Metabolism and excretion of [14C] febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase, in healthy male subjects.

Grabowski BA, Khosravan R, Vernillet L, Mulford DJ. Grabowski BA, et al. J Clin Pharmacol. 2011 Feb;51(2):189-201. doi: 10.1177/0091270010365549. Epub 2010 Mar 30. J Clin Pharmacol. 2011. PMID: 20354234 Clinical Trial.

The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.

Denissen JF, Grabowski BA, Johnson MK, Boyd SA, Uchic JT, Stein H, Cepa S, Hill P. Denissen JF, et al. Among authors: grabowski ba. Drug Metab Dispos. 1994 Nov-Dec;22(6):880-8. Drug Metab Dispos. 1994. PMID: 7895605

Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.

Khosravan R, Grabowski BA, Wu JT, Joseph-Ridge N, Vernillet L. Khosravan R, et al. Among authors: grabowski ba. Clin Pharmacokinet. 2006;45(8):821-41. doi: 10.2165/00003088-200645080-00005. Clin Pharmacokinet. 2006. PMID: 16884320 Clinical Trial.

Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans.

Kumar GN, Jayanti VK, Johnson MK, Uchic J, Thomas S, Lee RD, Grabowski BA, Sham HL, Kempf DJ, Denissen JF, Marsh KC, Sun E, Roberts SA. Kumar GN, et al. Among authors: grabowski ba. Pharm Res. 2004 Sep;21(9):1622-30. doi: 10.1023/b:pham.0000041457.64638.8d. Pharm Res. 2004. PMID: 15497688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results